Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RESTORE: ONO-2952 in IBS-D
NCT01887002Phase 2Terminated
- Sponsor
- Ono Pharmaceutical
- Start
- Jun 2013
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ONO-2952 in Irritable bowel syndrome with diarrhea (IBS-D), sponsored by Ono Pharmaceutical. Started Jun 2013; status: terminated.
02
Drugs
ONO-2952
03
Conditions
Irritable bowel syndrome with diarrhea (IBS-D)
Beyond the preview
Go deeper on NCT01887002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01887002.